Vitamin D in synergy with triple therapy to eradicate Helicobacter pylori infection in mice via the c-Raf/MEK/ERK pathway.
OpenAlex 토픽 ·
Helicobacter pylori-related gastroenterology studies
Protein Tyrosine Phosphatases
NF-κB Signaling Pathways
[BACKGROUND] Helicobacter pylori (H.
APA
Shuai Zhao, Chengyan Shan, et al. (2026). Vitamin D in synergy with triple therapy to eradicate Helicobacter pylori infection in mice via the c-Raf/MEK/ERK pathway.. Tissue & cell, 102, 103551. https://doi.org/10.1016/j.tice.2026.103551
MLA
Shuai Zhao, et al.. "Vitamin D in synergy with triple therapy to eradicate Helicobacter pylori infection in mice via the c-Raf/MEK/ERK pathway.." Tissue & cell, vol. 102, 2026, pp. 103551.
PMID
42033901
Abstract
[BACKGROUND] Helicobacter pylori (H. pylori) is a primary pathogen associated with gastritis, peptic ulcers, and gastric cancer. Current eradication therapies are increasingly compromised by antibiotic resistance. Vitamin D (VD) has shown potential as an adjunct therapy, yet its underlying mechanism remains unclear.
[OBJECTIVE] This study evaluated the efficacy of VD combined with triple therapy on H. pylori eradication in mice, assessing pathological changes, infection and inflammation levels and epithelial cell death; furthermore, it explored the mechanism of the synergistic effect.
[METHODS] An in vivo model was inoculated with H. pylori to establish in mice. After four weeks, mice were treated with VD, triple therapy, quadruple therapy (omeprazole, amoxicillin, clarithromycin and bismuth potassium citrate), or their combinations for another four weeks. Hematoxylin and Eosin (H&E) staining, quantitative real-time PCR, colony formation, immunoblotting, enzyme-linked immunosorbent assay (ELISA), TUNEL staining, and caspase activity assays were used to evaluate the effect of VD.
[RESULTS] Compared to triple therapy alone, the combination of VD and triple therapy reduced gastritis severity, H. pylori 16S rDNA expression, and bacterial colony counts in infected mice. It also decreased mRNA and protein levels of inflammatory cytokines IL-1β, IL-6, and TNF-α, reduced gastric epithelial cell apoptosis, and suppressed caspase-3/6/9 activities. VD treatment further enhanced c-Raf, MEK, and ERK phosphorylation in gastric tissues. Importantly, the ERK inhibitor U0126 abrogated the therapeutic benefits of VD combined with triple therapy, leading to increased gastritis severity, H. pylori 16S rDNA expression, bacterial colony counts, and caspase activity.
[CONCLUSION] Vitamin D3 synergizes with triple therapy to eradicate H. pylori infection by exhibiting antibacterial, anti-inflammatory, and cytoprotective effects through regulation of the c-Raf/MEK/ERK signaling pathway.
[OBJECTIVE] This study evaluated the efficacy of VD combined with triple therapy on H. pylori eradication in mice, assessing pathological changes, infection and inflammation levels and epithelial cell death; furthermore, it explored the mechanism of the synergistic effect.
[METHODS] An in vivo model was inoculated with H. pylori to establish in mice. After four weeks, mice were treated with VD, triple therapy, quadruple therapy (omeprazole, amoxicillin, clarithromycin and bismuth potassium citrate), or their combinations for another four weeks. Hematoxylin and Eosin (H&E) staining, quantitative real-time PCR, colony formation, immunoblotting, enzyme-linked immunosorbent assay (ELISA), TUNEL staining, and caspase activity assays were used to evaluate the effect of VD.
[RESULTS] Compared to triple therapy alone, the combination of VD and triple therapy reduced gastritis severity, H. pylori 16S rDNA expression, and bacterial colony counts in infected mice. It also decreased mRNA and protein levels of inflammatory cytokines IL-1β, IL-6, and TNF-α, reduced gastric epithelial cell apoptosis, and suppressed caspase-3/6/9 activities. VD treatment further enhanced c-Raf, MEK, and ERK phosphorylation in gastric tissues. Importantly, the ERK inhibitor U0126 abrogated the therapeutic benefits of VD combined with triple therapy, leading to increased gastritis severity, H. pylori 16S rDNA expression, bacterial colony counts, and caspase activity.
[CONCLUSION] Vitamin D3 synergizes with triple therapy to eradicate H. pylori infection by exhibiting antibacterial, anti-inflammatory, and cytoprotective effects through regulation of the c-Raf/MEK/ERK signaling pathway.
같은 제1저자의 인용 많은 논문 (5)
- Perioperative strategies for resectable EGFR-Mutant NSCLC: evidence hierarchy and clinical decision-making.
- A novel bicyclic peptide-drug conjugate of 3-fluoro-10-hydroxy-evodiamine for targeted colorectal cancer therapy.
- DNA Logic Gate-Integrated Peptide Nucleic Acid-Optical Fiber Sensor for Ultrasensitive Breast Cancer Exosome Profiling.
- Anatomy-guided visual prompt tuning for cross-modal breast cancer understanding.
- A machine learning approach to identify optimal candidates for transarterial chemoembolization in unresectable HBV-related hepatocellular carcinoma complicated by first-branch portal vein tumor thrombus: a multicenter study.